Patent Yard Sign in
Expired Canadian patentCanada

Ni-based single crystal super alloy

CA 2508698 C · Owner: Koizumi, Yutaka · Inventors: Arai, Mikiya; Yokokawa, Tadaharu; Masaki, Shoju

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The object of the present invention is to provide an Ni-based single crystal super alloy , capable of improving strength by preventing precipitation of a TCP phase at high temperatures. , This object is achieved by an Ni-based single crystal super alloy having a composition comprising , 5.0-7.0 wt% of Al 4.0-10.0 wt% of Ta, 1.1-4.5 wt% of Mo, 4.0-10.0 wt% of W 3.1-8.0 wt% of , Re, 0-0.50 wt% of Hf, 2.0-5.0 wt% of Cr 0-9.9 wt% of Co and 4.1-14.0 wt% of , Ru in terms of its weight ratio, with the remainder consisting of Ni and unavoidable impurities.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 5, 2003 and granted May 15, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 5, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 5, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 5, 2003
GrantedMay 15, 2012
Term endedDecember 5, 2023
Patent numberCA 2508698 C
Classification (IPC)C22C19/05

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedDec 5, 2003Patent grantedMay 15, 2012Term endedDec 5, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.